New Delhi: Drug firm Suven Life Sciences on Tuesday reported a marginal decline in standalone net profit to Rs 24.72 crore for the second quarter ended September 30.
The company had posted a net profit of Rs 24.83 crore for the July-September period of the previous fiscal, Suven Life Sciences said in a regulatory filing.
Standalone net sales during the quarter under review was also down 16.49 per cent to Rs 116.76 crore as against Rs 139.83 crore in the year-ago period.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
